Page last updated: 2024-12-05

n-hexane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

hexane : An unbranched alkane containing six carbon atoms. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8058
CHEMBL ID15939
CHEBI ID29021
MeSH IDM0086689

Synonyms (123)

Synonym
ch3-[ch2]4-ch3
CHEBI:29021 ,
hexan
dipropyl
gettysolve-b
normal hexane
hexane, commercial grade (52% n-hexane, 16% 3-methylpentane, 16% methylcyclopentane)
skellysolve b
hexyl hydride
hexanen
wln: 6h
heksan
esani
nsc68472
nsc-68472
LMFA11000007
hexane, puriss., >=95% (gc)
inchi=1/c6h14/c1-3-5-6-4-2/h3-6h2,1-2h
hsdb 91
esani [italian]
einecs 203-777-6
un1208
ccris 6247
hexanen [dutch]
heksan [polish]
nsc 68472
nci-c60571
ai3-24253
n-hexane ,
110-54-3
hexane
68476-44-8
92112-69-1
hexane, puriss., absolute, over molecular sieve (h2o <=0.01%), >=99.0% (gc)
hexane, puriss. p.a., acs reagent, >=99.0% (gc)
hexane, anhydrous, 95%
hexane, spectrophotometric grade, >=95%
680AF2EE-A7B6-479B-BFB3-0F5354069F72
H1197
AKOS000269046
CHEMBL15939
FT-0657006
H0490
H0394
H0405
A802211
NCGC00248828-01
1-hexane
cas-110-54-3
NCGC00258331-01
dtxsid0021917 ,
dtxcid001917
tox21_200777
senofilcon c
478799-92-7
2ce3ajr3m4 ,
n-hexan
hexanes [un1208] [flammable liquid]
ec 203-777-6
unii-2ddg612ed8
2ddg612ed8 ,
FT-0627031
EPITOPE ID:116866
hexane [usp-rs]
n-hexane [mi]
hexane [inci]
n-hexane [hsdb]
hexane [ii]
n-hexane [mart.]
exxsol hexane (salt/mix)
hexh
n-c6h14
normal-hexane
STL445663
n-hexane, environmental grade
mfcd00009520
n-hexane, spectrophotometric grade
n-hexane, hplc grade
butane, ethyl-
J-002443
n-hexane hplc grade
n-hexane, anhydrous
hexane, for hplc
hexane, suitable for determination of dioxins
hexane, puriss. p.a., acs reagent, reag. ph. eur., >=99% (gc)
hexane, analytical standard
hexane, laboratory reagent, >=95%
hexane fraction, purum
hexane, for hplc, >=97.0% (gc)
hexane, for hplc, >=95%
hexane, jis special grade, >=96.0%
hexane, saj first grade, >=95.0%
hexane, reagentplus(r), >=99%
hexane, purification grade, 95%
hexane, >=96.0%, suitable for residual phthalate analysis
hexane, purum, >=98.0% (gc)
hexane, for hplc, >=99%
hexane, p.a., 95.0%
hexane, uv hplc spectroscopic, 97%
hexane, ar, >=99%
hexane, vetec(tm) reagent grade, anhydrous, >=95%
hexane, p.a.
hexane, acs reagent, 99%
hexane, technical grade
hexane, p.a., 95%
hexane, pharmaceutical secondary standard; certified reference material
hexane; nsc 68472; skellysolve b; n-hexane
n-hexane, 95% min. glass distilled hrgc/hplc trace grade
n-hexane, acs grade
n-hexane 100 microg/ml in methanol
Q150440
AMY22305
n-hexane, p.a.
hexane, commercial grade (52% n-hexane, 16% 3-methylcyclopentane, 16% methylcyclopentane)
hexanes, mixture of isomers, for spectroscopy
n-hexane 1000 microg/ml in methanol
50981-41-4
senofilcon c [usan]
hexane (dot)
n-hexane (mart.)
hexane (ii)
ch3-(ch2)4-ch3
hexane (n)

Research Excerpts

Toxicity

Chronic toxic effects of n-hexane on the central nervous system were shown.

ExcerptReferenceRelevance
" From this evoked potentials study, chronic toxic effects of n-hexane on the central nervous system were shown."( Neurotoxic effects of n-hexane on the human central nervous system: evoked potential abnormalities in n-hexane polyneuropathy.
Chang, YC, 1987
)
0.83
" The minimum concentration of the chemicals at which enzyme leakage from hepatocytes was significantly increased was defined as the lowest toxic concentration (TCL0)."( [Toxicity assessments of chemical substances using primary culture of rat hepatocytes].
Fang, JF; Ishikawa, S; Kitagawa, Y; Manabe, S; Nakajima, K; Wada, O; Yanagisawa, H, 1986
)
0.27
" The 13-week exposures had no adverse effect on the growth of female rats."( A 13-week vapor inhalation study of n-hexane in rats with emphasis on neurotoxic effects.
Casey, HW; Cavender, FL; Graham, DG; Gralla, EJ; Salem, H; Swenberg, JA, 1984
)
0.54
" Despite their utility, these foam plugs can be quite toxic to plants, particularly to small seedlings."( Elimination of toxicity from polyurethane foam plugs used for plant culture.
Langhans, RW; Schwartzkopf, SH; Tibbitts, TW; Wheeler, RM, 1985
)
0.27
"Diesel exhaust particles (DEP) are known to induce adverse biological responses such as inflammation of the airway."( Oxidative ability and toxicity of n-hexane insoluble fraction of diesel exhaust particles.
Kobayashi, T; Koike, E; Shima, H; Shinohara, R, 2006
)
0.61
"3-Butene-1,2-diol (butenediol), a major metabolite of 1,3-butadiene (butadiene), can undergo either detoxification or biotransformation to potentially toxic metabolites, including 3,4-epoxy-1,2-butanediol and hydroxymethylvinyl ketone (HMVK)."( Effect of n-hexane on the disposition and toxicity of the 1,3-butadiene metabolite 3-butene-1,2-diol.
Bird, MG; Iba, MM, 2007
)
0.74
" Group II was toxic control and was given a single dose of CCl(4) on 8th days."( Lygodium flexuosum extract down regulates the expression of proinflammatory cytokines in CCl4-induced hepatotoxicity.
Asha, VV; Wills, PJ, 2012
)
0.38
"To investigate the toxic effects of n-hexane on the Ganod of female mice."( The effect of n-hexane on the gonad toxicity of female mice.
Huang, HL; Liu, J; Pang, F; Zhang, WC, 2012
)
1.01
" The crude extract was less toxic to the Vero cells (LC50=82 µg/ml) than ursolic acid (LC50=25 µg/ml)."( Antifungal activity and cytotoxicity of isolated compounds from leaves of Breonadia salicina.
Eloff, JN; Mahlo, SM; McGaw, LJ, 2013
)
0.39
" Besides, female mice were more sensitive to the toxic effect of HECb at 1000 mg/kg, which initially presented typical agitation signals, followed by depression signals, leading to death of all the animals at 24h."( Evaluation of toxicity of Calophyllum brasiliense stem bark extract by in vivo and in vitro assays.
Dall'Oglio, EL; de Oliveira Martins, DT; de Oliveira, RG; de Sousa Júnior, PT; Lemos, LM; Oliveira, MC, 2014
)
0.4
" This suggests that HECb is relatively safe in humans at its effective dose."( Evaluation of toxicity of Calophyllum brasiliense stem bark extract by in vivo and in vitro assays.
Dall'Oglio, EL; de Oliveira Martins, DT; de Oliveira, RG; de Sousa Júnior, PT; Lemos, LM; Oliveira, MC, 2014
)
0.4
" The results obtained revealed that ICIS 9 and ICIS 53 have safe properties and have the potential to be developed as probiotics."( Probiotic Potential, Safety Properties, and Antifungal Activities of Corynebacterium amycolatum ICIS 9 and Corynebacterium amycolatum ICIS 53 Strains.
Cherkasov, SV; Chertkov, KL; Gladysheva, IV; Kataev, VY; Khlopko, YA; Valyshev, AV, 2023
)
0.91
"Hexane is a widely used organic solvent in industry, and chronic hexane poisoning is the main occupational toxic lesion in China."( [Progress on the mechanism of n-hexane induced toxic effects in vitro and in vivo].
Feng, WT; Liu, JJ; Zhang, LJ, 2023
)
1.2

Pharmacokinetics

ExcerptReferenceRelevance
"Biological exposure index (BEI) of n-hexane was studied for accuracy using a physiologically based pharmacokinetic (PB-PK) model."( "Dynamic" biological exposure indexes for n-hexane and 2,5-hexanedione, suggested by a physiologically based pharmacokinetic model.
Brugnone, F; Mozzo, P; Olivato, D; Perbellini, L, 1990
)
0.82
" Pharmacokinetic analysis was performed using a monocompartmental model."( Influence of N-hexane inhalation on the enantioselective pharmacokinetics and metabolism of verapamil in rats.
Boralli, VB; Lanchote, VL; Lepera, JS; Marques, MP; Mateus, FH, 2010
)
0.73
"A rapid and sensitive liquid chromatography-tandem mass spectrometric method (LC-MS/MS) for the determination of bromotetrandrine in rat plasma has been developed and applied to pharmacokinetic study in Sprague-Dawley (SD) rats after a single oral administration."( Liquid chromatographic/mass spectrometry assay of bromotetrandrine in rat plasma and its application to pharmacokinetic study.
Li, Q; Liu, C; Song, N; Zhang, S, 2009
)
0.35
" The method was found to be suitable for the quantification of atenolol in a pharmacokinetic study after a single oral administration of 100 mg atenolol to 18 healthy subjects."( Determination of atenolol in human plasma by HPLC with fluorescence detection: validation and application in a pharmacokinetic study.
Niopas, I; Spanakis, M, 2013
)
0.39

Compound-Compound Interactions

ExcerptReferenceRelevance
"This investigation was designed to study the neurotoxicity produced in hens by the aliphatic hexacarbons n-hexane, methyl n-butyl ketone (MnBK), 2,5-hexanediol (2,5-HDOH), and 2,5-hexanedione (2,5-HD) following daily dermal application of each chemical alone and in combination with O-ethyl O-4-nitrophenyl phenylphosphonothioate (EPN)."( Pattern of neurotoxicity of n-hexane, methyl n-butyl ketone, 2,5-hexanediol, and 2,5-hexanedione alone and in combination with O-ethyl O-4-nitrophenyl phenylphosphonothioate in hens.
Abou-Donia, MB; Campbell, GM; Makkawy, HM, 1985
)
0.78
"In this study, off-line two-dimensional High Speed Counter-Current Chromatography (2D HSCCC) strategy combined with recycling elution mode was developed to isolate compounds from the ethyl acetate extract of a common green tea--leaves of Malus hupehensis (Pamp."( Separation of polyphenols from leaves of Malus hupehensis (Pamp.) Rehder by off-line two-dimensional High Speed Counter-Current Chromatography combined with recycling elution mode.
Chen, X; Jiang, S; Liu, Q; Yang, F; Yang, H; Zeng, H; Zhang, L, 2015
)
0.42

Bioavailability

ExcerptReferenceRelevance
" These data call attention to the fact that the absorption rate is higher before steady state is attained."( The in vitro permeability of human skin to benzene, ethylene glycol, formaldehyde, and n-hexane.
Lodén, M, 1986
)
0.49
" So it's valuable to test the absorption rate of C60 and obtain the changing curve in real time."( [The negative temperature effect of UV absorbance on C60 in different solvents].
Ge, Q; Guo, F; Xiong, Q; Yang, T; Zeng, FQ; Zhang, XG, 2004
)
0.32
" Methanol has been introduced in mixture with n-hexane in order to increase the bioavailability of n-hexane in trickle-bed-air-biofilters (TBABs)."( Effect of methanol on the biofiltration of n-hexane.
Hassan, AA; Sorial, GA; Zehraoui, A, 2012
)
0.9
" In both types of PSA, a constant absorption rate was maintained for up to 23 h after 7-h lag time."( In vivo enhancement of transdermal absorption of ketotifen by supersaturation generated by amorphous form of the drug.
Inoue, K; Sugibayashi, K, 2012
)
0.38
" DEP/MET modified the mucus profile of the epithelium, while DEP/HEX altered mucus extrusion, and these responses might be due to bioavailability of individual elements in DEP fractions."( Organic and inorganic fractions of diesel exhaust particles produce changes in mucin profile of mouse trachea explants.
Corrêa, AT; Junqueira, MS; Macchione, M; Martins, MA; Mauad, T; Saldiva, PH; Seriani, R; Silva, LF; Toledo, AC, 2015
)
0.42
" Thus, quality evaluation of different crystal forms should be assessed especially the solubility and dissolution behaviors among polymorphic forms, which correlate to bioavailability and therapy efficacy."( Polymorphic properties and dissolution profile of efavirenz due to solvents recrystallization.
Soewandhi, SN; Suendo, V; Wardhana, YW; Wikarsa, S, 2019
)
0.51

Dosage Studied

Dose-dependent effects were observed between the dosage of n-hexane and 2, 5-hexanedione, and pyrrole adducts in tissues. Adult male Wistar rats were administered intraperitoneally at a dosage of 400 mg/kg/day 2,5- hexanedione for 4 weeks.

ExcerptRelevanceReference
" In contrast to this, however, enolase isozymes were not significantly changed by either dosage level in both nervous tissue and skeletal muscle."( Effects of chronic n-hexane exposure on nervous system-specific and muscle-specific proteins.
Hisanaga, N; Huang, J; Kato, K; Ono, Y; Shibata, E; Sugimura, K; Takeuchi, Y, 1989
)
0.61
" The liver microsomal metabolism of n-hexane increased to about the same extent at all dosage levels."( Phthalate esters: effects of orally administered dibutylphthalate on cytochrome P-450 mediated metabolism in rat liver and lung.
Nilsen, OG; Walseth, F, 1986
)
0.55
" The present review covers clinical signs and symptoms, pathological changes, metabolism, dose-response (effect) in acute exposure, glue or thinner sniffers, workers, animal experiments."( [Toxicity and dose-response (effect) relationship of n-hexane (author's transl)].
Hisanaga, N; Inoue, T; Ono, Y; Takeuchi, Y, 1980
)
0.51
" Hepatic microsomes were prepared from groups of rats prior to dosing and at 2, 5, 12, and 24 hr postdosing with DCE (100 mg/kg ip), and total P450 content and the activity of CYP2E1 was determined."( Do endogenous volatile organic chemicals measured in breath reflect and maintain CYP2E1 levels in vivo?
Bucher, JR; Etheridge, AS; Mathews, JM; Raymer, JH; Velez, GR, 1997
)
0.3
" Enzyme dosage had the most significant effect on the incorporation, followed by reaction time, reaction temperature, solvent amount, and substrate ratio."( Lipase-catalyzed acyl exchange of soybean phosphatidylcholine in n-Hexane: a critical evaluation of both acyl incorporation and product recovery.
Mu, H; Vikbjerg, AF; Xu, X,
)
0.37
" This study indicates that ACRH extract could be a promising skin tumor promotion suppressing agent at a lower dosage (30 mg/kg)."( Suppression of DMBA/croton oil-induced mouse skin tumor promotion by Ardisia Crispa root hexane extract.
Fezah, O; Roslida, A; Yeong, LT, 2011
)
0.37
" To investigate the change of NFs degradation and their possible role in n-hexane neuropathy, adult male Wistar rats were administered intraperitoneally at a dosage of 400 mg/kg/day 2,5-hexanedione (2,5-HD) for 4 weeks."( 2,5-hexanedione altered the degradation of low-molecular-weight neurofilament in rat nerve tissues.
Gao, Y; Kou, R; Song, F; Xie, K; Zhang, Q; Zou, C, 2012
)
0.61
"Dose-dependent effects were observed between the dosage of n-hexane and 2, 5-hexanedione, and pyrrole adducts in tissues."( Correlation between levels of 2, 5-hexanedione and pyrrole adducts in tissues of rats exposure to n-hexane for 5-days.
Guo, Y; Xie, K; Yin, H; Zeng, T; Zhao, X, 2013
)
0.85
"A novel and reproducible isocratic normal phase liquid chromatographic method was developed for the quantitative determination of 10 stereoisomers of Nebivolol in pharmaceutical bulk drugs and dosage forms."( A validated chiral LC method for enantiomeric separation of nebivolol stereoisomers in bulk drugs and dosage forms on amylose-based stationary phase.
Haldar, P; Padmaja Reddy, K; Visweswara Rao, K, 2014
)
0.4
" The key variables selected were the concentration of dioxins in n-hexane and the dosage of activated carbon."( Adsorption of polychlorinated dibenzo-p-dioxins/dibenzofurans on activated carbon from hexane.
Buekens, A; Cen, KF; Li, XD; Ni, MJ; Zhou, XJ, 2016
)
0.67
" Temperatures, pH, initial oil concentration, dosage of sorbent, and time were found to be significant in the batch sorption investigation."( Abstraction and regeneration potential of temperature-enhanced rice husk montmorillonite combo for oil spill.
Akpomie, KG; Ezeofor, CC; Ezeorah, CJ; Odewole, OA; Olikagu, CS, 2018
)
0.48
" Results showed that the increased pyrrole adducts in hair, urine and serum accumulated in dose-response relationship."( Hair pyrrole adducts serve as biomarkers for peripheral nerve impairment induced by 2,5-hexanedione and n-hexane in rats.
Li, M; Li, X; Wang, Q; Wang, S; Xie, K; Zhang, C, 2018
)
0.7
" Therefore, the physicochemical properties of polymorphic forms from active pharmaceutical ingredients (APIs) should be carefully considered in dosage forms pre-formulation approaches."( Polymorphic properties and dissolution profile of efavirenz due to solvents recrystallization.
Soewandhi, SN; Suendo, V; Wardhana, YW; Wikarsa, S, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
non-polar solventnull
neurotoxinA poison that interferes with the functions of the nervous system.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
alkaneAn acyclic branched or unbranched hydrocarbon having the general formula CnH2n+2, and therefore consisting entirely of hydrogen atoms and saturated carbon atoms.
volatile organic compoundAny organic compound having an initial boiling point less than or equal to 250 degreeC (482 degreeF) measured at a standard atmospheric pressure of 101.3 kPa.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency21.62380.000323.4451159.6830AID743065
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (43)

Assay IDTitleYearJournalArticle
AID1756067Antibiofilm activity against Pseudomonas aeruginosa ATCC 50071 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
AID1756081Antibiofilm activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756083Antibiofilm activity against Escherichia coli DSM 8579 assessed as inhibition of bacterial metabolism within the biofilm at 40 ug/ml measured after 48 hrs by MTT assay relative to control
AID23718Partition coefficient in water-hexadecane (P16) was determined2003Bioorganic & medicinal chemistry letters, Feb-10, Volume: 13, Issue:3
QSAR study on solubility of alkanes in water and their partition coefficients in different solvent systems using PI index.
AID1756078Antibiofilm activity against Listeria monocytogenes ATCC 7644 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID23737Partition coefficient (logP)2003Bioorganic & medicinal chemistry letters, Feb-10, Volume: 13, Issue:3
QSAR study on solubility of alkanes in water and their partition coefficients in different solvent systems using PI index.
AID1756068Antibiofilm activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1081323Nematicidal activity against Bursaphelenchus xylophilus at 0.5 mg/ml measured after 48 hr under microscope2010Journal of agricultural and food chemistry, Feb-10, Volume: 58, Issue:3
Structure-activity relationship of aliphatic compounds for nematicidal activity against pine wood nematode (Bursaphelenchus xylophilus).
AID1756064Antibiofilm activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1756072Antibiofilm activity against Escherichia coli DSM 8579 assessed as inhibition of biofilm formation at 80 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1756065Antibiofilm activity against Pectobacterium carotovorum ATCC 15713 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID23726Partition coefficient in alkanes was determined2003Bioorganic & medicinal chemistry letters, Feb-10, Volume: 13, Issue:3
QSAR study on solubility of alkanes in water and their partition coefficients in different solvent systems using PI index.
AID1756061Antibiofilm activity against Listeria monocytogenes ATCC 7644 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID603950In-vitro air to lung partition coefficients of the compound, logK(lung) (human/rat)2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID532769Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph mutant2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID1756062Antibiofilm activity against Pseudomonas aeruginosa ATCC 50071 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID603952In-vitro blood to lung partition coefficients of the compound, logP(lung) (human/rat)2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID1756077Antibiofilm activity against Pectobacterium carotovorum ATCC 15713 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756080Antibiofilm activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756070Antibiofilm activity against Pectobacterium carotovorum ATCC 15713 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID532772Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant in presence of IPTG2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID1682590Cytotoxicity against human HL-60 cells assessed as reduction in cell viability incubated for 48 hrs by CCK-8 assay2021Bioorganic & medicinal chemistry letters, 01-01, Volume: 31Cytotoxic components from the leaves of Erythrophleum fordii induce human acute leukemia cell apoptosis through caspase 3 activation and PARP cleavage.
AID532770Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph mutant in presence of chlorpromazine2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID1756073Antibiofilm activity against Listeria monocytogenes ATCC 7644 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756074Antibiofilm activity against Pseudomonas aeruginosa ATCC 50071 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756076Antibiofilm activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756075Antibiofilm activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial metabolism within the biofilm at 4 ug/ml measured after 48 hrs by MTT assay relative to control
AID532768Antimicrobial activity against Salmonella serovar Typhimurium SL1344 in presence of chlorpromazine2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID532773Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant in presence of IPTG and chlorpromzine2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID532771Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant2008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID1756082Antibiofilm activity against Pectobacterium carotovorum ATCC 15713 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID603951In-vitro air to blood partition coefficients of the compound, logK(blood) (human/rat)2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID1756084Antibiofilm activity against Escherichia coli DSM 8579 assessed as inhibition of bacterial metabolism within the biofilm at 80 ug/ml measured after 48 hrs by MTT assay relative to control
AID532767Antimicrobial activity against Salmonella serovar Typhimurium SL13442008Antimicrobial agents and chemotherapy, Oct, Volume: 52, Issue:10
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
AID26047logBB, log(C brain / C blood)1996Journal of medicinal chemistry, Nov-22, Volume: 39, Issue:24
Computation of brain-blood partitioning of organic solutes via free energy calculations.
AID1756071Antibiofilm activity against Escherichia coli DSM 8579 assessed as inhibition of biofilm formation at 40 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID1756069Antibiofilm activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
AID1756066Antibiofilm activity against Listeria monocytogenes ATCC 7644 assessed as inhibition of biofilm formation at 8 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
AID13316Solubility in water was determined; values expressed as -log2003Bioorganic & medicinal chemistry letters, Feb-10, Volume: 13, Issue:3
QSAR study on solubility of alkanes in water and their partition coefficients in different solvent systems using PI index.
AID1756079Antibiofilm activity against Pseudomonas aeruginosa ATCC 50071 assessed as inhibition of bacterial metabolism within the biofilm at 8 ug/ml measured after 48 hrs by MTT assay relative to control
AID1756063Antibiofilm activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of biofilm formation at 4 ug/ml measured after 48 hrs by crystal violet staining based assay relative to control
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,265)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990162 (12.81)18.7374
1990's162 (12.81)18.2507
2000's233 (18.42)29.6817
2010's535 (42.29)24.3611
2020's173 (13.68)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 87.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index87.00 (24.57)
Research Supply Index7.22 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index158.50 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (87.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials11 (0.81%)5.53%
Reviews35 (2.59%)6.00%
Case Studies38 (2.81%)4.05%
Observational0 (0.00%)0.25%
Other1,266 (93.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]